Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vivek Mohan
Institution:
Artemis Hospitals
Observed institutions:
Paras Hospitals,
Artemis Hospitals
ORCID:
0000-0002-7553-0677
Observed ORCID:
0000-0002-7553-0677
OpenAlex ID:
A5103276887
Low‐dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe‐BIRD) in a child with relapsed/refractory B‐cell acute lymphoblastic leukemia with TP53 mutation
2024
·
Vivek Mohan
, Sachin Jain
, et al.
·
Pediatric Blood & Cancer
·
3
Extracorporeal Membrane Oxygenation for Pneumocystis jirovecii Pneumonia in a Child With Multisystem Langerhans Cell Histiocytosis
2026
·
Vivek Mohan
, Sanjay Kumar
, et al.
·
Journal of Pediatric Hematology/Oncology
Second autologous hematopoietic stem cell transplantation in multiple myeloma
2026
·
Disha Kakkar
, Vivek Mohan
, et al.
·
Indian Journal of Cancer
Multiple Myeloma as a Second Primary Malignancy
2026
·
T. S. Aathira
, Vivek Mohan
, et al.
·
Indian Journal of Hematology and Blood Transfusion
Polatuzumab vedotin and obinutuzumab combination in octogenarians with B-cell non-Hodgkin lymphoma
2026
·
Avishek Chakravorty
, Bhuvanesh N. Purohit
, et al.
·
Journal of Cancer Research and Therapeutics
Refractory immune thrombocytopenia with Trex1 mutation positive probable monogenic lupus
2025
·
Bhuvnesh Narain Purohit
, Vivek Mohan
, et al.
·
Blood Cells Molecules and Diseases
Lower-dose venetoclax (LoVe) based regimes in children with acute leukemia
2025
·
Bhuvanesh Narayan Purohit
, Vivek Mohan
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Inotuzumab Ozogamicin in Indian Patients with B-Cell Acute Lymphoblastic Leukemia
2024
·
Pronamee Borah
, Vivek Mohan
, et al.
·
Indian Journal of Hematology and Blood Transfusion
Show more works
View as search
Works count:
8
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
